Request Information
Request Information
Mar 23 2018
Fierce Biotech
Fred Moll’s Auris Health has been granted FDA clearance for its surgical robotics platform. The nod clears the Intuitive Surgical founder’s latest venture to sell the device for use in bronchoscopic diagnostic and therapeutic procedures in lung cancer patients.
Auris, formerly known as Auris Surgical Robotics, kept a low profile over its first decade but the few details that leaked out whetted appetites. The startup is founded and run by Moll, who played a key role in making Intuitive Surgical and its da Vinci Surgical System the defining company and device of the first era of robotic surgery. And it has raised a load of cash, with last year’s $280 million series D round moving the total up above $500 million.
Read the Full Article about AurisBronchoscopy:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.